ATA Guidelines Tools

Anaplastic Thyroid Cancer ATA 2021

American Thyroid Association Quick-Reference GUIDELINES Apps

Issue link: https://eguideline.guidelinecentral.com/i/1441026

Contents of this Issue

Navigation

Page 23 of 27

24 Treatment Table 4. Informed Consent Checklist The three components of informed consent involve: • Disclosure • Decision-Making Capacity • Voluntariness Disclosure: • Truthful prognostication • Treatment options available and all associated side-effects, ranging from aggressive treatment to palliative care and hospice, including the option of medical assistance in dying. Consent for Treatment Discuss Advance Directives, code status, and naming a surrogate decision maker. • Surgical Management ▶ Surgical candidacy and expected benefits and risks ▶ Discussion of intubation and tracheostomy • Drug Therapies ▶ Candidacy and contraindications ▶ Costs and expected benefit ratio ▶ Expected and rare side-effects ▶ When to stop the drug if risks outweigh benefits • External Beam Radiation ▶ Candidacy and contraindications ▶ All side-effects and palliation of side-effects ▶ When to stop radiation if risks outweigh benefits Decision-making capacity: a • After the disclosure discussion, do a "teach back" with the following questions to assess Understanding (U), Appreciation (A), Rationality (R), and ability to Express a choice (E) (U-ARE) ▶ What do you understand about your situation? ▶ What are your treatment options? ▶ What will happen when you take/do not take this treatment? ▶ Why do you want/not want it? ▶ What other choices do you have? ▶ How did you arrive at your choice? ▶ What questions do you have? ▶ What are you worried about?

Articles in this issue

Archives of this issue

view archives of ATA Guidelines Tools - Anaplastic Thyroid Cancer ATA 2021